Baader Bank »

Monte Rosa Therapeutics shares owned by Baader Bank

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Baader Bank from 13F filings

Historical chart of Baader Bank investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Baader Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Baader Bank

Quarter filed Position value Share count Share price at filing
2025-12-31 $173k 11k 15.68

More positions owned by Baader Bank

Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Oracle Corporation (ORCL)
Linde SHS (LIN)
Robinhood Mkts Com Cl A (HOOD)
Apple (AAPL)
Adobe Systems Incorporated (ADBE)
NVIDIA Corporation (NVDA)
Palantir Technologies Cl A (PLTR)
Paypal Holdings (PYPL)
salesforce (CRM)
Pdd Holdings Sponsored Ads (PDD)
Berkshire Hathaway Inc Del Cl A (BRK.A)

View all positions for Baader Bank

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Baker Bros. Advisors
TCG Crossover Management
Versant Venture Management
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
State Street Corporation
Aisling Capital Management
American Century Companies
Geode Capital Management
MPM Oncology Impact Management
Silverarc Capital Management

View all funds holding Monte Rosa Therapeutics